Table 1.
Baseline demographics.
Total | Placebo | LF | |
---|---|---|---|
Number | 109 | 49 | 60 |
Male, n (%) | 56 (51.4) | 28 (57.1) | 28 (46.7) |
Age, months | 25.8 ± 4.9 | 25.7 ± 5.2 | 25.9 ± 4.6 |
Body height, cm | 84.2 ± 5.0 | 84.2 ± 5.7 | 84.1 ± 4.4 |
Body weight, kg | 11.5 ± 1.4 | 11.5 ± 1.5 | 11.6 ± 1.4 |
Weight-for-age, z-score | −011. ± 0.98 | −0.16 ± 1.00 | −0.06 ± 0.98 |
Height-for-age, z-score | −0.57 ± 1.18 | −0.56 ± 1.15 | −0.58 ± 1.21 |
Weight-for-height, z-score | 0.07 ± 0.23 | 0.05 ± 0.22 | 0.08 ± 0.23 |
Siblings, n | 0.87 ± 0.78 | 0.84 ± 0.80 | 0.90 ± 0.76 |
No. of family members in the household, n | 3.07 ± 1.08 | 2.98 ± 1.05 | 3.15 ± 1.11 |
Frequency of attending nursery schools, times/week | 5.06 ± 0.36 | 5.08 ± 0.28 | 5.03 ± 0.42 |
Respiratory infections in the past 6 months | 3.05 ± 1.18 | 3.29 ± 1.12 | 2.85 ± 1.21 |
Vaccine history | |||
Rotavirus, n (%) | 58 (64.5) | 36 (73.5) | 33 (56.9) |
Influenza, n (%) | 66 (61.1) | 27 (55.1) | 39 (66.1) |
Values represent the mean ± standard deviation.